Search

A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.

… Wednesday, March 29, 2023 Highlights MSK researchers identified a key role for the STING signaling pathway in preventing dormant metastatic cancer cells from progressing to active metastases. Treating laboratory mice with a STING activator helped eliminate lingering metastatic cells and stop the development

An innovative technique called stereotactic hypofractionated accelerated radiation to the prostate – aka SHARP - safely and effectively delivers powerful doses of radiation directly to the patient’s tumor with incredible precision.

… Friday, June 2, 2017 For decades, experts at Memorial Sloan Kettering have been pioneering sophisticated ways to safely and effectively deliver powerful doses of radiation directly to a person’s tumor with incredible precision. One recent example of these ongoing efforts is an innovative technique called

New MSK research showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.

… Wednesday, July 31, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and

Recent data from Memorial Sloan Kettering shows that a real-time breast ultrasound exam after second opinion review of outside, static breast ultrasound images led to a change in the initially prescribed management in 32.5 percent of included patients.

… Monday, October 16, 2017 Asymptomatic women who undergo routine breast cancer screening with imaging may be uncertain of the next steps when an unexpected suspicious finding or cancer is reported in the context of their annual visit with a primary care doctor in the community setting. For these women

Traveling with cancer can be done, even if you’re in active treatment. Plan ahead so that you can fully enjoy your vacation.

… Thursday, June 30, 2016 Summary Having cancer doesn’t mean you can’t visit loved ones and exciting locales. Learn how to make the most of your travels if you’re currently in active treatment. Highlights You can minimize the stress of traveling by planning and preparing in advance. Check in with your

A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems.

… Monday, February 3, 2014 A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems. The $6.7 million project may translate into new treatments that benefit older people and those who have received a bone marrow transplant. The initiative – called

A vital part of MSK's mission is to get patients back to feeling like themselves.

… Wednesday, July 12, 2017 VIDEO | 01:35 MSK's Dental Service Aims to Make People Whole Again Medical artist Marjorie Golden and Dental Service Chief Joseph Huryn create lifelike facial prostheses for patients. Video Details Summary A vital part of MSK’s mission is to get patients back to feeling like

MSK’s comprehensive program for patients with upper tract urothelial carcinoma (UTUC) offers kidney-sparing treatment options whenever possible.

… Tuesday, April 16, 2024 MSK’s comprehensive program for patients with upper tract urothelial carcinoma (UTUC) offers kidney-sparing treatment options whenever possible. “Traditionally, radical nephroueterectomy has been the gold standard for managing high-risk UTUC,” said  urologic surgeon Jonathan Coleman

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation.

… Friday, July 1, 2011 Summary Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation. Charles L. Sawyers , Chair of the Human Oncology and Pathogenesis Program , is a co-recipient

First-year students reflect on the impact of the first-year core curriculum on their careers.

… Thursday, April 1, 2010 Our current first-year students arrived on July 27, 2009, and during their first laboratory rotation began laying the foundation for developing a dissertation. After five weeks of bench work, they entered the classroom to tackle the core course, taking breaks from this didactic